Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
KPT330 and CRISPR-Cas9 Precision Editing
2026-09-21
The reference study identifies selective inhibitors of nuclear export, including KPT330, as indirect modulators that reduce Cas9 activity by disrupting Cas9 mRNA export rather than directly blocking the nuclease. Its findings suggest that controlling the duration and localization of Cas9 expression can improve genome- and base-editing specificity in mammalian cells, while also highlighting important translational and safety limitations.
-
Cistanche Nanovesicles Rescue Sertoli Cell Cycling
2026-09-21
This reference study reports that Cistanche deserticola exosome-like nanovesicles alleviate cyclophosphamide-induced testicular injury by targeting Sertoli-cell cycle arrest. Its central mechanism connects heparan sulfate proteoglycan-mediated uptake with miR159b-3p regulation of P21 and CDK1, while human single-cell transcriptomic data provide initial relevance to non-obstructive azoospermia.
-
ZK53: Human Mitochondrial ClpP Activator Guide
2026-09-20
ZK53 combines selective human ClpP activation with practical workflows for mitochondrial proteostasis, tumor metabolism, and ferroptosis research. Its orthogonal biochemical readouts, cell-line starting points, and reported xenograft regimens help researchers connect target engagement to measurable biological outcomes.
-
Penicillin G Sodium: Applied Bacterial Workflows
2026-09-19
Penicillin G Sodium supports controlled bacterial challenge studies, contamination management, and cell-wall perturbation assays when exposure, growth phase, and resistance status are defined. This practical guide combines product-specific handling with orthogonal viability measurements and assay logic adapted from a cited canine tumor-cell study.
-
EdU Imaging Kits (Cy3) for S-Phase Assays
2026-09-18
EdU Imaging Kits (Cy3) provide a denaturation-free route to quantify DNA synthesis while preserving cell morphology and antigen accessibility. The workflow is especially useful for linking cell-cycle activity to insect gut biology, RNAi perturbation, microscopy, flow cytometry, and genotoxicity testing.
-
Heparin sodium in Nanovesicle and Coagulation Workflows
2026-09-18
Heparin sodium combines dependable anticoagulation with a practical mechanistic probe for blood handling, thrombosis assays, and exploratory nanovesicle-uptake studies. This guide connects anti-factor Xa and aPTT workflows with the HSPG-dependent uptake findings reported for Cistanche deserticola nanovesicles, while separating validated uses from testable hypotheses.
-
TAK-242 for TLR4 Neuroinflammation Studies
2026-09-17
TAK-242 (Resatorvid) gives researchers a selective way to test whether TLR4 drives LPS-responsive inflammation, oxidative stress, and neuroinflammatory phenotypes. This practical guide connects nanomolar cell assays with an aged-rat perioperative neurocognitive disorder model while emphasizing controls, dose selection, and troubleshooting.
-
Heparin Sodium at the HSPG–Assay Interface
2026-09-17
Heparin sodium is more than a coagulation reagent: its polyanionic structure offers a useful lens for interpreting anti-factor Xa, aPTT, and heparan sulfate proteoglycan uptake experiments. This article connects anticoagulant assay design with recent findings on plant-derived nanovesicles while defining the limits of that cross-domain comparison.
-
Heparin sodium in Nanovesicle and Coagulation Assays
2026-09-16
Heparin sodium serves both as a dependable glycosaminoglycan anticoagulant for coagulation assays and as a mechanistic competition probe in heparan sulfate proteoglycan-dependent nanovesicle uptake studies. This workflow-oriented guide connects anti-factor Xa and aPTT readouts with practical controls for Sertoli-cell and plant-derived nanovesicle experiments.
-
Luminescent ATP Detection Assay Kit for Colitis
2026-09-16
Use a sensitive firefly luciferase ATP assay to add functional energy-state data to ulcerative colitis experiments, from LPS-stimulated epithelial cells to colon tissue. The workflow combines gentle lysis, broad ATP linearity, and downstream protein compatibility for more informative NOX2/ROS/mitochondrial studies.
-
HyperScribe T7 High Yield Cy3 RNA Labeling Kit Guide
2026-09-15
Build bright, application-ready RNA probes for in situ hybridization and Northern blot workflows with tunable Cy3-UTP incorporation. This practical guide connects probe synthesis and assay controls to the nanoparticle-enabled RNAi findings reported in Bemisia tabaci research.
-
EdU Imaging Kits (Cy3) for S-Phase Assays
2026-09-15
EdU Imaging Kits (Cy3) convert DNA replication into a bright, countable Cy3 signal without the DNA denaturation required by many BrdU workflows. This article translates the assay into practical microscopy and flow-cytometry workflows, with a kidney-development use case based on Drosha-regulated mesangial-cell proliferation.
-
3-Deazaadenosine: Designing Better Methylation Assays
2026-09-14
3-Deazaadenosine is an S-adenosylhomocysteine hydrolase inhibitor for dissecting methylation-dependent biology. This article connects its metabolic mechanism with recent m6A research and shows how to design assays that distinguish global methylation pressure from pathway-specific causality.
-
PEDV Hijacks IMPDH-Dependent Nucleotide Biosynthesis
2026-09-14
Zhou and colleagues show that porcine epidemic diarrhea virus (PEDV) depends on host IMPDH2 and guanine-nucleotide biosynthesis for efficient replication. By combining comparative metabolomics, IMPDH2 knockdown, and Merimepodib (VX-497) treatment, the study identifies host nucleotide metabolism as a mechanistically supported antiviral target while also revealing important cell-type-specific metabolic responses.
-
IFN-γ Engineering Makes Tumor Cells Tumoricidal
2026-09-13
The reference study shows that tumor cells can be reprogrammed to express T-cell effector genes and acquire both self-restraining and bystander tumoricidal activity. IFNG overexpression produced the strongest effect among the tested programs, suppressing wild-type tumor growth in vitro and in vivo without evident toxicity.